Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Share-based Compensation (2016 - 2025)

CorMedix (CRMD) has disclosed Share-based Compensation for 12 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 200.71% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Dec 2025, up 125.68% year-over-year, with the annual reading at $13.8 million for FY2025, 125.68% up from the prior year.
  • Share-based Compensation hit $3.6 million in Q4 2025 for CorMedix, down from $4.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2025 to a low of $50000.0 in Q2 2022.
  • Historically, Share-based Compensation has averaged $1.7 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Share-based Compensation: plummeted 95.05% in 2022 and later soared 1878.0% in 2023.
  • Year by year, Share-based Compensation stood at $1.3 million in 2021, then tumbled by 30.26% to $874051.0 in 2022, then increased by 8.69% to $950000.0 in 2023, then grew by 25.63% to $1.2 million in 2024, then skyrocketed by 200.71% to $3.6 million in 2025.
  • Business Quant data shows Share-based Compensation for CRMD at $3.6 million in Q4 2025, $4.1 million in Q3 2025, and $2.7 million in Q2 2025.